Loading insider details...
Beta
Latest Form 4 (Nov 8, 2024): Sale of 61 ATXI shares, $136.64.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 8, 2024 | AVENUE THERAPEUTICS, INC. (ATXI) | Sale | 61 | $136.64 |
| Oct 1, 2024 | AVENUE THERAPEUTICS, INC. (ATXI) | Purchase | 3 | $7.20 |
| Sep 25, 2024 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/Award | 30,000 | n/a |
| Jul 5, 2023 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/Award | 100,000 | n/a |
| Dec 21, 2021 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/Award | 49,020 | n/a |
| Jun 16, 2020 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/Award | 10,000 | n/a |